Status:
TERMINATED
Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Parathyroid Neoplasm
Parathyroid Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have alre...
Detailed Description
While a successful neck exploration for PHP is primarily dependent on the experience of the surgeon, there are currently several localizing studies available to increase success. Although the necessit...
Eligibility Criteria
Inclusion
- Subjects who are 18 years and over
- subjects who have had a failed parathyroidectomy and now presents with persistent hyperparathyroidism or recurrent hyperparathyroidism
- 6 control patients with parathyroid adenomas who have not yet had surgery will be selected to test the efficacy of the software.
Exclusion
- Potential female subjects who are pregnant
- Any potential subject who has an implanted metallic device, stent or staples
- any subject weighing 300lb
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00639405
Start Date
September 1 2005
End Date
August 1 2008
Last Update
April 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210